Description
Scope of the Report:
The global Addictions Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Addictions Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Addictions Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Addictions Therapeutics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Alkermes Plc
Opiant Pharmaceuticals Inc.
Johnson & Johnson Services Inc.
Amneal Pharmaceuticals Inc.
Novo Nordisk AS
Indivior Plc
Teva Pharmaceutical Industries Ltd.
Novartis AG
Mylan NV
Pfizer Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market Segment by Applications, can be divided into
Public
Private
Government
Scope of the Report:
The global Addictions Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Addictions Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Addictions Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Addictions Therapeutics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Alkermes Plc
Opiant Pharmaceuticals Inc.
Johnson & Johnson Services Inc.
Amneal Pharmaceuticals Inc.
Novo Nordisk AS
Indivior Plc
Teva Pharmaceutical Industries Ltd.
Novartis AG
Mylan NV
Pfizer Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market Segment by Applications, can be divided into
Public
Private
Government
Table of Contents
1 Addictions Therapeutics Market Overview
• 1.1 Product Overview and Scope of Addictions Therapeutics
• 1.2 Classification of Addictions Therapeutics by Types
o 1.2.1 Global Addictions Therapeutics Revenue Comparison by Types (2019-2024)
o 1.2.2 Global Addictions Therapeutics Revenue Market Share by Types in 2018
o 1.2.3 Alcohol Addiction Therapeutics
o 1.2.4 Tobacco Addiction Therapeutics
o 1.2.5 Drug Addiction Therapeutics
• 1.3 Global Addictions Therapeutics Market by Application
o 1.3.1 Global Addictions Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
o 1.3.2 Public
o 1.3.3 Private
o 1.3.4 Government
• 1.4 Global Addictions Therapeutics Market by Regions
o 1.4.1 Global Addictions Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
o 1.4.1 North America (USA, Canada and Mexico) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.2 Europe (Germany, France, UK, Russia and Italy) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.4 South America (Brazil, Argentina, Colombia) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Addictions Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Addictions Therapeutics (2014-2024)
2 Company Profiles
• 2.1 Alkermes Plc
o 2.1.1 Business Overview
o 2.1.2 Addictions Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
o 2.1.3 Alkermes Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Opiant Pharmaceuticals Inc.
o 2.2.1 Business Overview
o 2.2.2 Addictions Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
o 2.2.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Johnson & Johnson Services Inc.
o 2.3.1 Business Overview
o 2.3.2 Addictions Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
o 2.3.3 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Amneal Pharmaceuticals Inc.
o 2.4.1 Business Overview
o 2.4.2 Addictions Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
o 2.4.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Novo Nordisk AS
o 2.5.1 Business Overview
o 2.5.2 Addictions Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
o 2.5.3 Novo Nordisk AS Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Indivior Plc
o 2.6.1 Business Overview
o 2.6.2 Addictions Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
o 2.6.3 Indivior Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Teva Pharmaceutical Industries Ltd.
o 2.7.1 Business Overview
o 2.7.2 Addictions Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
o 2.7.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Novartis AG
o 2.8.1 Business Overview
o 2.8.2 Addictions Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
o 2.8.3 Novartis AG Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Mylan NV
o 2.9.1 Business Overview
o 2.9.2 Addictions Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
o 2.9.3 Mylan NV Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Pfizer Inc.
o 2.10.1 Business Overview
o 2.10.2 Addictions Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
o 2.10.3 Pfizer Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Addictions Therapeutics Market Competition, by Players
• 3.1 Global Addictions Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
o 3.2.1 Top 5 Addictions Therapeutics Players Market Share
o 3.2.2 Top 10 Addictions Therapeutics Players Market Share
• 3.3 Market Competition Trend
4 Global Addictions Therapeutics Market Size by Regions
• 4.1 Global Addictions Therapeutics Revenue and Market Share by Regions
• 4.2 North America Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Addictions Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Addictions Therapeutics Revenue by Countries
• 5.1 North America Addictions Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Addictions Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Addictions Therapeutics Revenue by Countries
• 6.1 Europe Addictions Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Addictions Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Addictions Therapeutics Revenue by Countries
• 7.1 Asia-Pacific Addictions Therapeutics Revenue by Countries (2014-2019)
• 7.2 China Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Addictions Therapeutics Revenue by Countries
• 8.1 South America Addictions Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Addictions Therapeutics by Countries
• 9.1 Middle East and Africa Addictions Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Addictions Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Addictions Therapeutics Market Segment by Type
• 10.1 Global Addictions Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Addictions Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Alcohol Addiction Therapeutics Revenue Growth Rate (2014-2024)
• 10.4 Tobacco Addiction Therapeutics Revenue Growth Rate (2014-2024)
• 10.5 Drug Addiction Therapeutics Revenue Growth Rate (2014-2024)
11 Global Addictions Therapeutics Market Segment by Application
• 11.1 Global Addictions Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 Addictions Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Public Revenue Growth (2014-2019)
• 11.4 Private Revenue Growth (2014-2019)
• 11.5 Government Revenue Growth (2014-2019)
12 Global Addictions Therapeutics Market Size Forecast (2019-2024)
• 12.1 Global Addictions Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global Addictions Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Addictions Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
• 14.1 Methodology
1 Addictions Therapeutics Market Overview
• 1.1 Product Overview and Scope of Addictions Therapeutics
• 1.2 Classification of Addictions Therapeutics by Types
o 1.2.1 Global Addictions Therapeutics Revenue Comparison by Types (2019-2024)
o 1.2.2 Global Addictions Therapeutics Revenue Market Share by Types in 2018
o 1.2.3 Alcohol Addiction Therapeutics
o 1.2.4 Tobacco Addiction Therapeutics
o 1.2.5 Drug Addiction Therapeutics
• 1.3 Global Addictions Therapeutics Market by Application
o 1.3.1 Global Addictions Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
o 1.3.2 Public
o 1.3.3 Private
o 1.3.4 Government
• 1.4 Global Addictions Therapeutics Market by Regions
o 1.4.1 Global Addictions Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
o 1.4.1 North America (USA, Canada and Mexico) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.2 Europe (Germany, France, UK, Russia and Italy) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.4 South America (Brazil, Argentina, Colombia) Addictions Therapeutics Status and Prospect (2014-2024)
o 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Addictions Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Addictions Therapeutics (2014-2024)
2 Company Profiles
• 2.1 Alkermes Plc
o 2.1.1 Business Overview
o 2.1.2 Addictions Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
o 2.1.3 Alkermes Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Opiant Pharmaceuticals Inc.
o 2.2.1 Business Overview
o 2.2.2 Addictions Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
o 2.2.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Johnson & Johnson Services Inc.
o 2.3.1 Business Overview
o 2.3.2 Addictions Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
o 2.3.3 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Amneal Pharmaceuticals Inc.
o 2.4.1 Business Overview
o 2.4.2 Addictions Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
o 2.4.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Novo Nordisk AS
o 2.5.1 Business Overview
o 2.5.2 Addictions Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
o 2.5.3 Novo Nordisk AS Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Indivior Plc
o 2.6.1 Business Overview
o 2.6.2 Addictions Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
o 2.6.3 Indivior Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Teva Pharmaceutical Industries Ltd.
o 2.7.1 Business Overview
o 2.7.2 Addictions Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
o 2.7.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Novartis AG
o 2.8.1 Business Overview
o 2.8.2 Addictions Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
o 2.8.3 Novartis AG Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Mylan NV
o 2.9.1 Business Overview
o 2.9.2 Addictions Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
o 2.9.3 Mylan NV Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Pfizer Inc.
o 2.10.1 Business Overview
o 2.10.2 Addictions Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
o 2.10.3 Pfizer Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Addictions Therapeutics Market Competition, by Players
• 3.1 Global Addictions Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
o 3.2.1 Top 5 Addictions Therapeutics Players Market Share
o 3.2.2 Top 10 Addictions Therapeutics Players Market Share
• 3.3 Market Competition Trend
4 Global Addictions Therapeutics Market Size by Regions
• 4.1 Global Addictions Therapeutics Revenue and Market Share by Regions
• 4.2 North America Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Addictions Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Addictions Therapeutics Revenue by Countries
• 5.1 North America Addictions Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Addictions Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Addictions Therapeutics Revenue by Countries
• 6.1 Europe Addictions Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Addictions Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Addictions Therapeutics Revenue by Countries
• 7.1 Asia-Pacific Addictions Therapeutics Revenue by Countries (2014-2019)
• 7.2 China Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Addictions Therapeutics Revenue by Countries
• 8.1 South America Addictions Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Addictions Therapeutics by Countries
• 9.1 Middle East and Africa Addictions Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Addictions Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Addictions Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Addictions Therapeutics Market Segment by Type
• 10.1 Global Addictions Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Addictions Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Alcohol Addiction Therapeutics Revenue Growth Rate (2014-2024)
• 10.4 Tobacco Addiction Therapeutics Revenue Growth Rate (2014-2024)
• 10.5 Drug Addiction Therapeutics Revenue Growth Rate (2014-2024)
11 Global Addictions Therapeutics Market Segment by Application
• 11.1 Global Addictions Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 Addictions Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Public Revenue Growth (2014-2019)
• 11.4 Private Revenue Growth (2014-2019)
• 11.5 Government Revenue Growth (2014-2019)
12 Global Addictions Therapeutics Market Size Forecast (2019-2024)
• 12.1 Global Addictions Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global Addictions Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America Addictions Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Addictions Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
• 14.1 Methodology
